TY - JOUR
T1 - Patents as surrogates for inimitable and non-substitutable resources
AU - Markman, Gideon D.
AU - Espina, Maritza I.
AU - Phan, Phillip H.
PY - 2004/8
Y1 - 2004/8
N2 - This study tests the view that competitive advantage lies in organizational processes and capabilities to secure patents. Since, by definition, patents are valuable and rare, here we test the extent to which patent citations and claims capture, respectively, inimitability and non-substitutability. Focusing on 85 publicly traded pharmaceutical firms (SIC 2834), we find that once the effects of firm size, past performance, and investment in innovation are held constant, inimitability is significantly related to firm profitability and new product introductions. Non-substitutability is significantly related to new product introductions only.
AB - This study tests the view that competitive advantage lies in organizational processes and capabilities to secure patents. Since, by definition, patents are valuable and rare, here we test the extent to which patent citations and claims capture, respectively, inimitability and non-substitutability. Focusing on 85 publicly traded pharmaceutical firms (SIC 2834), we find that once the effects of firm size, past performance, and investment in innovation are held constant, inimitability is significantly related to firm profitability and new product introductions. Non-substitutability is significantly related to new product introductions only.
UR - http://www.scopus.com/inward/record.url?scp=2342550635&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2342550635&partnerID=8YFLogxK
U2 - 10.1016/j.jm.2003.09.005
DO - 10.1016/j.jm.2003.09.005
M3 - Article
AN - SCOPUS:2342550635
SN - 0149-2063
VL - 30
SP - 529
EP - 544
JO - Journal of Management
JF - Journal of Management
IS - 4
ER -